HRT Financial LP (WOK) nets 2.64M-share swing in WORK Medical stock

Rhea-AI Filing Summary

WORK Medical Technology Group LTD reported that major shareholder HRT Financial LP, a ten percent owner, both bought and sold its common stock in closely timed trades. On June 15, 2026, HRT Financial LP purchased 268,927 shares in an open-market transaction at $0.095 per share.

The next day, June 16, 2026, it executed an open-market sale of 2,904,567 common shares at $0.058 per share. After these transactions, HRT Financial LP directly held 391,456 WORK Medical common shares, with no derivative positions reported in this filing.

Insights

Equity ownership analyst

HRT Financial LP made a large net sale while retaining a smaller remaining WOK stake.

The filing shows HRT Financial LP, identified as a ten percent owner of WORK Medical Technology Group LTD, carrying out both an open-market purchase and an open-market sale of common stock on consecutive days.

It bought 268,927 shares at $0.095 on June 15, 2026, then sold 2,904,567 shares at $0.058 on June 16, 2026, for a net disposition of 2,635,640 shares. Following these trades, it directly held 391,456 shares, and the filing lists no remaining derivative securities.

These are discretionary open-market transactions rather than option exercises or tax withholdings. Actual implications depend on broader share count and prior holdings, which are outside this single filing.

Insider Trade Summary

Net Seller: 2,635,640 shares ($168,465)

Net Sell 2 txns

Insider HRT FINANCIAL LP

Role null

Bought 268,927 shs ($26K)

Sold 2,904,567 shs ($168K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,904,567	$0.058	$168K
Purchase	Common Stock	268,927	$0.095	$26K

Holdings After Transaction: Common Stock — 391,456 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 2,904,567 shares Sale price: $0.058 per share Shares purchased: 268,927 shares +3 more

6 metrics

Shares sold 2,904,567 shares Open-market sale of common stock on June 16, 2026 at $0.058

Sale price $0.058 per share Price for 2,904,567 WORK Medical common shares sold June 16, 2026

Shares purchased 268,927 shares Open-market purchase of common stock on June 15, 2026 at $0.095

Purchase price $0.095 per share Price for 268,927 WORK Medical common shares bought June 15, 2026

Net share change 2,635,640 shares Net disposition across the two reported trades

Shares held after 391,456 shares Direct WORK Medical common stock holding after June 16, 2026 sale

Key Terms

ten percent owner, open-market sale, open-market purchase, Form 4

4 terms

ten percent owner regulatory

"HRT Financial LP, a ten percent owner, both bought and sold its common stock"

open-market sale financial

"it executed an open-market sale of 2,904,567 common shares at $0.058 per share"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

open-market purchase financial

"purchased 268,927 shares in an open-market transaction at $0.095 per share"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Form 4 regulatory

"The Form 4 does not list any derivative securities"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
WORK Medical Technology Group LTD [ WOK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		P		268,927	A	$0.095	3,296,023	D
Common Stock	06/16/2026		S		2,904,567	D	$0.058	391,456	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	06/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider trades did HRT Financial LP report for WORK Medical (WOK)?

HRT Financial LP reported one open-market purchase and one open-market sale of WORK Medical common stock on June 15 and 16, 2026. The trades resulted in a large net reduction of shares held while leaving a remaining direct position reported in the filing.

How many WORK Medical (WOK) shares did HRT Financial LP sell and at what price?

HRT Financial LP sold 2,904,567 shares of WORK Medical common stock on June 16, 2026, in an open-market transaction at $0.058 per share. This sale followed a smaller purchase the prior day and significantly reduced its reported direct share holdings.

How many WORK Medical (WOK) shares did HRT Financial LP buy and at what price?

On June 15, 2026, HRT Financial LP bought 268,927 WORK Medical common shares at $0.095 per share in an open-market purchase. This purchase was immediately followed by a much larger sale the next day, creating a net decrease in its common stock position.

What is HRT Financial LP’s remaining WORK Medical (WOK) shareholding after these trades?

After completing the June 15–16, 2026 transactions, HRT Financial LP directly held 391,456 shares of WORK Medical common stock. The Form 4 does not list any derivative securities, so this figure reflects the reported residual common share stake in this filing.

Is HRT Financial LP considered a major shareholder of WORK Medical (WOK)?

Yes. HRT Financial LP is identified in the Form 4 as a ten percent owner of WORK Medical Technology Group LTD. That status indicates it owns, or recently owned, at least ten percent of the company’s registered class of securities covered by this insider reporting requirement.

Were the WORK Medical (WOK) trades by HRT Financial LP open-market transactions?

Both reported transactions are described as open-market dealings. The June 15, 2026 entry is an open-market purchase, while the June 16, 2026 entry is an open-market sale, each reflecting direct ownership with no indication of options exercises or tax-related dispositions.